Tandem Diabetes Care Inc (STU:TD5A)
€ 29.15 -1.65 (-5.36%) Market Cap: 1.92 Bil Enterprise Value: 1.92 Bil PE Ratio: 0 PB Ratio: 8.66 GF Score: 82/100

Tandem Diabetes Care Inc at Wolfe Research Healthcare Conference Transcript

Nov 15, 2023 / 03:15PM GMT
Release Date Price: €16.85 (+19.67%)
Michael K. Polark
Wolfe Research, LLC - Director & Senior Analyst

I'd like to start these sessions by just giving you the floor kind of state of play, update us on the quarter. I think, John, maybe to give you a specific prompt, you kind of called the current period of transitional time for Tandem. When do we -- when does the transitional period for Tandem end?

Questions & Answers

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Starting right now. I mean I'd say we've had some pressure from the last 18 months. Certainly, we've had some competitive pressures, some economic, hasn't been acting in our favor. I'd say, over the last several quarters this was stabilized. And we're about ready to enter this period of time where we have this wave of innovation that's going to be available for [Tandem].

And I think in my mind, it's the most exciting pipeline of diabetes today. We have 4 products that we're introducing, they are all going to be introduced in the next several weeks [back], I'd say. And the good news is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot